Liminatus Pharma, Inc. (LIMN) stock
LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
$2.81−0.16 (-5.39%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Liminatus Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
No price to book ratio figures for Liminatus Pharma
Liminatus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?